Distinguished Alumnus Award 2015 | Johns Hopkins Alumni

Robert Babb, A&S ’77
Bob Babb has served as the head baseball coach at Johns Hopkins University since 1980. In the 35 seasons since, he has established Johns Hopkins as a national power with more than 1,000 victories during that time. While his record of achievement on the field speaks for itself, it's what he has done off the field for the program and the University that separates him. An emphasis on academics is Babb's highest priority. In fact, 27 Blue Jay baseball players have earned Academic All-America honors. JHU's 27 Academic All-Americans are the most of any Division III baseball team in the nation. Babb has also utilized international travel with his team to spread the game and expose his players to different cultures around the world. The Johns Hopkins baseball program has made 10 such international trips since the first one in 1986.While victories and championships are typically the manner in which a coach's legacy is measured, Babb's will be even more visible as the Johns Hopkins baseball facility now bears his name (Babb Field at Stromberg Stadium). An initiative to construct one of the finest on-campus facilities in the nation was completed in September, 2014 with the dedication of the new home of Johns Hopkins baseball. More than 600 former players, friends and family members attended the dedication, proving for certain that Bob Babb's impact on the lives of those associated with his program extends far beyond what happens on the field.

Joanne Berger-Sweeney, BSPH ’89
Joanne was a student in the neurotoxicology program under the supervision of Dr. Zoltan Annau. Her dissertation advisor was Dr. Joseph Coyle and her supervisor was Dr. Christine Hohmann. After receiving her PhD in 1989, Joanne went to INSERM in Paris to do postdoctoral research. She then went on to Wellesley College in 1991 as an Assistant Professor and rose through the ranks to Professor and Lummis Russell Professor of Neuroscience. Joanne then became the Dean of the School of Arts and Sciences at Tufts University. In July 2014, Joanne was appointed as President of Trinity College in Hartford, Connecticut. This appointment marked a number of firsts for a president of Trinity. These included that Joanne is the first women, first African-American, first mother and first neuroscientist to be president. Dr. Berger-Sweeney has also received several awards including being a National Science Foundation Young Investigator and Society of Neuroscience Lifetime Mentoring Award recipient. She was elected councilor and then treasurer of the Society for Neuroscience and elected as a Fellow in the American Academy for the Advancement of Science (AAAS). It is obvious that Joanne has contributed in a number of ways that have contributed to society: researcher, mentor and academic administrator.

Kenneth I. Berns, Med ’66, A&S ’60, ’64
Kenneth I. Berns, M.D., Ph.D. recently retired as Director of the Genetics Institute at the University of Florida. Previously he served as Dean of the College of Medicine and Vice President for Health Affairs. Dr. Berns has devoted most of his scientific research career to the study of the molecular basis of replication of the human parvovirus, adeno-associated virus. He has been a major contributor to our knowledge concerning the ability of adeno-associated virus to establish latent infections and to be reactivated. His work has been instrumental in providing the basis for the current interest in the use of this virus as a vector for gene therapy. He also has had a longstanding interest in medical education and has served as a member of the Liaison Committee on Medical Education. He is a past member of the Composite Committee of the United States Medical Licensing Examination and is a past Chair of the Association of American Medical Colleges. Dr. Berns has served on many scientific advisory committees including the Genetic Biology Panel of the NSF, the Virology Study Section of the NIH, the Board of Scientific Counselors of the National Institute of Allergy and Infectious Diseases, the Virology-Microbiology panel of the American Cancer Society (Chair), the Recombinant DNA Advisory Committee (Chair) of the NIH and the National Advisory Research Resources Council (NARRC) of the NIH. He has also served similar roles for the EPA, the U.S. Army (NRC) and the Aaron Diamond AIDS Research Center. He is a member of the National Academy of Sciences and the Institute of Medicine of the National Academy of Sciences. Dr. Berns is currently a member of the National Science Advisory Board for Biosecurity. He is also a member of the Advisory Committee to the Director of the CDC and co-chairs the External Laboratory Safety Workgroup. Earlier he served as chair of the National Research Council’s “Standards and Policies for Decontaminating Public Facilities Affected by Exposure to Harmful Biological Agents: How Clean Is Safe?” This committee’s final product, Reopening Public Facilities after a Biological Attack: A Decision Making Framework, was completed in June of 2005. He also served on the Institute of Medicine Committee for Research Opportunities for Smallpox Virus, as well as the National Research Council Committee on the Metropolitan Medical Response to Weapons of Mass Destruction. Finally, he chairs the American Society for Microbiology Committee on Biodefense. Dr. Berns was an alumni trustee of the Johns Hopkins Board of Trustees 2000-2006 and currently serves as a member of the Advisory Board of the Institute for Basic Biomedical Sciences. He and Laura have a son, a daughter and two granddaughters.

Charles S. Bryan, Med ’67, A&S ’64
Charley, as he is known to his friends, returned to his Columbia, South Carolina, his hometown, in 1974 and has spent the past 40 years practicing internal medicine and infectious diseases while achieving national distinction was a clinician, researcher, medical school department chair, and author (more than 500 contributions to the medical literature and 12 books and monographs), and international distinction as an authority on Sir William Osler, about whom he’s written or co-edited four books and monographs and numerous articles. His most recent book (Asylum Doctor) chronicles mental illness and pellagra in South Carolina during a difficult time in the state’s history. Dr. Bryan helped to forge South Carolina’s early response to the HIV/AIDS epidemic and edited the Journal of the South Carolina Medical Association for more than 36 years (possibly a national record). A colleague refers to him as “the conscience of South Carolina Medicine” on account of his deep interest in clinical ethics, virtue theory, professionalism, and the state of medicine—past, present and future. Charley has received several national awards for his contributions to the medical humanities, is a Master of the American College of Physicians (and has been named South Carolina’s recipient of the Centennial Legacy Award of that organization), and has received the Order of the Palmetto, South Carolina’s highest award for non-military-related service. His intellectual curiosity, restless mind, and eloquence epitomize the old school of teaching. He has served as one of South Carolina’s most distinguished mentors, colleagues, friends, and ambassadors in numerous medical and lay capacities

Matthew S. Daimler, Engr ’99
Successful serial entrepreneur Matt Daimler is a problem solver by nature. After graduating with a computer engineering degree from Johns Hopkins, Matt observed the differences between seats on various cramped flights. The search for a better seat led him to found SeatGuru.com, a website that revolutionized the travel industry by allowing users to research the best seats offered by major airlines. After winning several major awards and incredible growth, industry leader Expedia purchased SeatGuru in early 2007. In 2010, Matt launched his second company, Buyfolio, as a solution to the cumbersome home buying process in New York City. Buyfolio was acquired by industry leader Zillow in 2012 and Matt was hired as VP Strategic Initiatives. Matt and his wife, Susan (currently serving as a Hopkins trustee), are active Johns Hopkins alumni, mentoring students interested in entrepreneurship, serving annually as judges in the JHU Business Plan Competition, and supporting the university through undergraduate scholarships.

Julie E. Goodman, BSPH ’00, ’02
Julie Goodman is an epidemiologist and board-certified toxicologist specializing in human health risk assessment. She received a SB in Environmental Engineering from the Massachusetts Institute of Technology, and a ScM in Epidemiology and a PhD in Environmental Health Sciences/Toxicology from the Johns Hopkins Bloomberg School of Public Health. Following this, she was a Cancer Prevention Fellow at the National Cancer Institute and worked in the Laboratory of Human Carcinogenesis. She is currently a Principal at Gradient, an environmental consulting firm, and an adjunct faculty member in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health. Her primary responsibilities at Gradient include the analysis and interpretation of epidemiology, toxicity, and mode-of-action evidence, apparent disease clusters, and chemical exposures. At Harvard, she teaches a graduate class in Research Synthesis and Meta-analysis. Dr. Goodman has made major contributions to public health by researching and developing weight-of-evidence methodologies that incorporate toxicology, epidemiology, and mechanistic data, including the Hypothesis-based Weight-of-evidence approach, and has also had significant local community engagement.

Elmer E. Huerta, BSPH ’92
Elmer Huerta is currently Director of the Cancer Preventorium, Washington Cancer Institute, MedStar Washington Hospital Center in Washington, DC. Noticing that his patients with advanced cancer knew more about soap operas and soccer than cancer prevention, he has dedicated 30 years to promote disease prevention and early detection to the public using the media. His radio and television programs reach Spanish-Speaking people in the United States and Latin America. At his Cancer Preventorium, founded in 1994, he has seen over 33,000 people, mostly poor and uninsured Latinos for prevention and early detection consultations. Through his educational work, Dr. Huerta -author of the best sellers “La Salud Hecho Fácil” and “Confrontando el Cáncer”- has developed a high degree of respect and trust in the Hispanic community at the local, national, and international level. He is senior medical contributor for CNN en Espanol. Dr. Huerta was appointed by President Clinton as member of the National Cancer Advisory Board in 1998 and was elected in 2007 as the first-ever Latino National President of the American Cancer Society. Dr. Huerta received the 2004 Innovations in Prevention Award by the Secretary of the Department of Health and Human Services and the 2013 White House Public Health and Prevention Champion of Change Award. Dr. Huerta was selected as one of the 100 Most Influential Hispanics in the United States in 2008 and in 2015 received a Honoris Causa doctorate degree by his alma mater Universidad Nacional Mayor de San Marcos. Dr. Huerta is a strong candidate for the Distinguished Alumnus Award for his educational and advocacy work as well as for his research, all of which have furthered the Hopkins tradition of excellence.

Wei-Ping A. Lee, Med ’83, Med Faculty
Dr. Wei-Ping Andrew Lee is the Milton T. Edgerton, MD, Professor and Chairman of the Department of Plastic and Reconstructive Surgery at the Johns Hopkins University School of Medicine. A hand surgeon and translational researcher, he conducts investigation on tolerance strategy for vascularized composite allografts (VCA), such as hand or face transplants, to ameliorate the need for long-term systemic immunosuppression. Dr. Lee established multi-disciplinary programs for hand transplantation at Johns Hopkins and University of Pittsburgh using an immunomodulatory protocol based upon investigations in his laboratory. He led the surgical team that performed the first bilateral hand transplant (2009) and the trans-humeral transplant (2010) in the U.S. A salient feature of the protocol is single-agent immunosuppression (monotherapy) that minimizes the long-term risks of VCA. Dr. Lee has mentored approximately 80 pre-doctoral and post-doctoral researchers in over two decades, and has authored over 180 original publications in peer-reviewed journal and 40 textbook chapters on hand surgery and composite tissue transplant subjects. He has been the principal investigator on federal research grants totaling over $10 million. The book co-edited by him, Transplantation of Composite Tissue Allografts, was published in 2008. He has been an invited speaker or visiting professor in about 60 institutions around the world, and served on the editorial boards of Transplantation and Journal of Surgical Research. In 2014 he co-founded the journal Vascularized Composite Allotransplantation, and serves as its co-Editor-in-Chief. Dr. Lee has received more than 90 awards and honors, including the Kappa Delta Award from the American Academy of Orthopaedic Surgeons, and Sumner Koch Award and Sterling Bunnell Traveling Fellowship from the American Society for Surgery of the Hand. In 2014 he was recognized by the American Association of Plastic Surgeons with the Research Achievement Award for Basic Research, and received in the same year the Andrew J. Weiland Medal for Outstanding Research from the American Society for Surgery of the Hand. In 2015, he was given the Distinguished Alumnus Award from Johns Hopkins University. Dr. Lee has served as the Chair of the American Board of Plastic Surgery (2012-13) and the President of the American Society for Surgery of the Hand (2011-12). In 2008 he co-founded the American Society for Reconstructive Transplantation, for which he currently serves as the President. He was elected the Chair of Plastic Surgery Research Council in 2002 and President of the Robert H. Ivy Society of Plastic Surgeons in 2010. An honors graduate in physics from Harvard College, Dr. Lee received his medical degree from Johns Hopkins University School of Medicine, where he also completed his general surgery residency and microvascular research fellowship. He completed his plastic surgery fellowship at the Massachusetts General Hospital and his orthopedic hand fellowship at the Indiana Hand Center. In 1993 he joined the plastic surgery faculty at Massachusetts General Hospital, and became the director of Plastic Surgery Research Laboratory and the chief of hand service in Department of Surgery. In 2002 Dr. Lee was appointed as the Division Chief of Plastic Surgery at the University of Pittsburgh. He was recruited to Johns Hopkins in 2010 to be the inaugural chairman of the Department of Plastic and Reconstructive Surgery. He has been appointed to chair the Associate Professor Promotion Committee of Johns Hopkins University School of Medicine, and was elected Vice Chair of the Medical Board at the Johns Hopkins Hospital.

Howard C. Mandel, A&S ’77
Howie Mandel has been a tremendous volunteer for Johns Hopkins University for decades, through his service on the Second Decade Society, the Krieger School Advisory Board, the University Board of Trustees and as Alumni Association President of the LA Chapter. However, is it his humanitarian service that brings credit to the University and makes him a highly appropriate candidate for the Distinguished Alumnus Award. He has not only volunteered at the Saban (Los Angeles) Free Clinic for three decades now, but he advocates prominently to our public officials for equal access to health care for women, children, the homeless, and the working poor. His influence is felt widely across our city, on the boards of multiple philanthropic organizations. Howie Mandel has served on “Obama for America Health Policy Advisory Committee’, was an advisor to Senator Biden on health care issues during his presidential campaign, and continues to advise Senator Mark Warner. In addition to teaching and lecturing on topics such as Ob/Gyn Emergencies, Women’s Health and Health Care Economics, he has appeared as an expert on numerous televisions news and informational programs on NBC, ABC, CNN and others.

Jenny G. Morgan, BSPH ’86
Jenny’s career includes C-level positions at multiple Baltimore-based companies as well as the nationally respected private-equity group Sterling Partners. Under her guidance, her companies grew so significantly that Morgan was a winner of the Ernst & Young Entrepreneur of The Year® Award and the Deloitte & Touche Technology Fast 50 award 3 years in a row. In addition, she just completed her 6 year term as the Chairperson of the Baltimore Branch of the Federal Reserve of Richmond. She is also a board member of Mirixa Corporation and Celebree Learning Centers. Jenny has joined the Dean's Advisory Council for Carey, and also served as the keynote orientation speaker in 2014

John J. Moriarty, A&S ’72
John is nationally a recognized leader in the construction industry. Following his early career work with Turner Construction Company, he founded John Moriarty & Associates (JMA) in 1985, where he currently serves as President. Significant projects include the newest project launched in Boston’s Seaport District, the largest construction project in Boston filling over 23 acres in South Boston. Other work includes the Mandel Center for Humanities at Brandeis and their Science Center; Yale’s Media and Technology Center and theirs School of Medicine Research Laboratory; student housing at MIT and Harvard; significant projects at mass General and Children’s Hospital; and Boston’s and Miami’s Art Museums. His buildings have won many awards, including a LEED Platinum certification from The U.S. Green Building Council for the National Grid Company’s headquarters. John’s career also includes significant volunteer work in his community. He served for more than 10 years as Chair of the Board of Trustees of Concord Academy, enabling the School to significantly expand its campus and full time faculty. He has served the Boston region as a counselor to numerous non-profits including the public school systems in Winchester and Boston. He was a member of the Parent’s Council Colby College and supports Leslie College in Boston where his wife, Carol, is a Trustee. John is a member of the Krieger School Advisory Board and recently served as a volunteer on the Hopkins committee led by Tony Deering that planned construction in Charles Village on 33rde Street and St. Paul.

Patricia Morton, Nurs ’77
Patricia G. Morton, is an educator and scholar who is known for her work in critical care nursing and nursing education. She has authored three textbooks, numerous book chapters, and over 50 journal articles. She has served on the editorial board of six nursing journals and for seven years was the editor of the journal AACN Clinical Issues: Advanced Practice in Acute and Critical Care. Currently, Dr. Morton is the editor of the Journal of Professional Nursing sponsored by the American Association of Colleges of Nursing. She has served on national committees for the past ten years including a three year appointment on the Board of Directors for American Association of Critical-Care Nurses. Currently, she is a member of the University of Utah Hospitals and Clinics (UUHC) Board of Trustees and the UUHC Health Care Executive Committee, a member of the Western Institute of Nursing, and a fellow in the American Academy of Nursing. In 2013, Dr. Morton joined the University of Utah as the Dean of the College of Nursing, where she is a tenured professor and holds the Louis H. Peery Presidential Endowed Chair. Prior to this position, Dr. Morton was a member of the faculty of the University of Maryland, School of Nursing for 33 years. She led the teams that developed the acute care nurse practitioner specialty, the nurse anesthesia specialty, and the Doctor of Nursing Practice program, and in the late 1980s, Dr. Morton developed the first simulation laboratory for the school. Dr. Morton also practiced as an acute care nurse practitioner at the University of Maryland Medical Center until she left her position in July of 2013.

Drew M. Pardoll, Med ’82, A&S ’77
Dr. Pardoll is an Abeloff Professor of Oncology, Medicine, Pathology and Molecular Biology and Genetics at the Johns Hopkins University, School of Medicine. He is Director of the Cancer Immunology in the Sidney Kimmel Comprehensive Cancer Center. Dr. Pardoll attended Johns Hopkins University, where he earned his M.D., Ph.D., in 1982 and completed his Medical Residency and Oncology Fellowship in 1985. He then worked for three years at the National Institutes of Health as a Medical Staff Fellow. Dr. Pardoll joined the departments of oncology and medicine in 1988. Dr. Pardoll has published over 300 papers as well as over 20 book chapters on the subject of T cell immunology and cancer vaccines. He has served on the editorial board of the Journal of the National Cancer Institute and Cancer Cell, and has served as a member of scientific advisory boards for the Cancer Research Institute, the University of Pennsylvania Human Gene Therapy Gene Institute, Biologic Resources Branch of the National Cancer Institute, Harvard-Dana Farber Cancer Center, Cerus Corporation, Global Medical Products Corporation, Genencor Corporation, CellGenesys Corporation, Mojave Therapeutics, the American Association of Clinical Oncology and the American Association of Cancer Research. Dr. Pardoll has made a number of basic advances in Cellular Immunology, including the discovery of gamma - delta T cells, NKT cells and interferon-producing killer dendritic cells. Over the past two decades, Dr. Pardoll has studied molecular aspects of dendritic cell biology and immune regulation, particularly related to mechanisms by which cancer cells evade elimination by the immune system. He is an inventor of a number of immunotherapies, including GVAX cancer vaccines and Listeria monocytogenes based cancer vaccines. Dr. Pardoll’s basic immunology discoveries include the identification of -T cells, NKT cells and IKDC. He elucidated the role of Stat3 signaling in tumor immune evasion and in Th17 development, leading to the discovery that Stat3-driven Th17 responses promote carcinogenesis. Dr. Pardoll discovered one of the two ligands for the PD-1 inhibitory receptor and leads the Hopkins cancer immunology program that developed PD-1 pathway-targeted antibodies, demonstrating their clinical activity in multiple cancer types. His more than 300 articles cover cancer vaccines, gene therapies, cancer prevention technologies, recombinant immune modulatory agents for specific pathways that regulate immunity to cancer and infectious diseases.

Ronald R. Peterson, A&S ’70
Ron Peterson became a science and math teacher in the Baltimore City public schools and taught adult education at night. He even supplemented his income by working part-time as a catering firm manager. Yet Peterson never lost his interest in medicine and by 1973, he had obtained a master’s degree in hospital administration from George Washington University. He leapt at an opportunity to do his administrative residency at Johns Hopkins – and has never left. He excelled as an administrator for the Phipps Psychiatric Clinic, the Hopkins Cost Improvement Program, and the Children’s Medical and Surgical Center, winning national plaudits for his cost-saving skills and one newspaper’s praise as “a fiscal surgeon.” In 1982, his mentor, Dr. Robert Heyssel, then-president of The Johns Hopkins Hospital, assigned Peterson to head the venerable, then-municipally owned Baltimore City Hospitals, which was mired in debt. The city had asked Hopkins to take over management of the 130-acre facility, which hadn’t been upgraded in decades and was running a $7 million deficit. The Peterson-led Hopkins management team significantly reduced the debt within a year and soon thereafter had it operating in the black. In 1984, upon Peterson’s recommendation, a joint committee of the University and Hopkins Hospital trustees agreed to acquire City Hospitals, re- naming it the Francis Scott Key Medical Center. In 1994, it was re-christened the Johns Hopkins Bayview Medical Center after a decade of tremendous advances and success. During the 17 years of Peterson’s leadership at Hopkins Bayview, it underwent an astounding $100 million transformation of its medical facilities, including massive renovations of existing structures and the building of a $15.5 million geriatrics center, a $60 million acute patient tower and a $13 million outpatient care center and medical services office building. In 1995, Peterson was named executive vice president and chief operating officer of the Johns Hopkins Health System, in order to bring stronger coordination and cohesion to its operations and strategic planning. By December 1996, Peterson had more than proved that he was supremely qualified to become the tenth president of The Johns Hopkins Hospital and Health System, which within two months would be consolidated into an entity known as Johns Hopkins Medicine. Peterson has been instrumental in over-seeing Hopkins Medicine’s expansion into an annual, $6 billion enterprise.

Angel Ruiz, Bus '83
President and CEO
Ericsson North America
A member of Ericsson’s Global Executive Leadership Team, Angel Ruiz is President and CEO of Ericsson’s Region North America. Ruiz has worked in the telecom industry for more than 32 years and has been with Ericsson for more than 22 years. Ericsson, a global leader in Information and Communication Technology (ICT), has 15,000 employees in North America and net sales in the U.S and Canada of $8 billion in 2014. Ruiz became head of the organization in North America in 2001 and set a vision of growth and customer quality. Under his leadership, Ericsson has become the number one provider of telecommunications solutions and services in the U.S. and Canada, a region that is leading the world in LTE network deployments. In 2010, Ruiz was awarded the Gifford K. Johnson Community Leadership Award from the University of Texas at Dallas for supporting and enabling activities such as research with UT Dallas faculty. Ruiz has been on numerous advisory boards, representing Ericsson. In 2012, the Dallas-Fort Worth Metroplex Technology and Business Council named him CEO of the year for his numerous contributions to the area and the telecommunications industry. Ruiz has served on CTIA’s Board of Directors and on its Executive Committee for more than a decade, making him one of the Executive Committee’s longest-serving members. In addition, he has chaired CTIA’s Suppliers’ Council since 2009. In 2013, President Barack Obama named Ruiz as a member of the President’s National Security Telecommunications Advisory Committee. In 2014, Ruiz was appointed to the board of directors for Liberty Mutual Holding Company, the parent corporation of the Liberty Mutual Insurance group of entities. Ruiz joined Ericsson in 1990 and has held a variety of technical, sales and managerial positions within the company. He has worked abroad in managerial and customer support assignments in Mexico, Venezuela and Sweden. Before joining Ericsson, Ruiz held various positions with Sprint, AT&T and Bell Atlantic. Ruiz holds a Bachelor’s degree in Electrical Engineering from the University of Central Florida and a Master’s degree in Management Science and Information Systems from Johns Hopkins University in Baltimore, Maryland.

Ellen K. Silbergeld, BSPH Faculty, Engr ’72
Ellen Silbergeld, a MacArthur Genius, has contributed in a number of areas and her contributions in each area have been remarkable and significant. She is recognized worldwide for her contributions to critical studies of lead toxicity, she demonstrated the CNS effects in young animals and the relationship to the human condition. In studies of gold miners in Amazonia, she carried out both epidemiological and experimental studies demonstrating that mercury exposures, from the processing of gold, affects the immune system and increases the prevalence of malaria. In the last few years, Ellen has been working on the contribution of antibiotic use in feeds for chickens and pigs, contributes to the selection for and dissemination of antibiotic resistance in human pathogens, including MRSA. She has completed a book on this topic, which is in press at the Johns Hopkins University Press. After getting her Ph.D. in engineering, and her postdoctoral training at Bloomberg, she worked at NIH, University of Maryland, Environmental Defense Fund before returning to Hopkins as a Professor of Environmental Health Science. She has close to 250 peer-reviewed papers, many book chapters and editorial, among other publications.

Gregory (Reid) Wisemen, Engr ’06
Gregory Reid Wiseman is a test pilot in the US Navy and active NASA Astronaut. Wiseman was commissioned through the Reserve Officers’ Training Corps (ROTC) following graduation from Rensselaer Polytechnic Institute in 1997 and reported to Pensacola, Florida, for flight training. He was designated as a Naval Aviator in 1999 and reported to Fighter Squadron 101, Naval Air Station Oceana, Virginia, for transition to the F-14 Tomcat. Following his initial training, Wiseman was assigned to Fighter Squadron 31, also at Oceana, and made two deployments to the Middle East, supporting Operations Southern Watch, Enduring Freedom and Iraqi Freedom. During his second deployment in 2003, he was selected to attend the U.S. Naval Test Pilot School, Class 125. Following graduation in June 2004, Wiseman was assigned as a Test Pilot and Project Officer at Air Test and Evaluation Squadron Two Three (VX-23) at Naval Air Station Patuxent River, Maryland. At VX-23, Wiseman earned his master’s degree and worked various flight test programs involving the F-35 Lightning II, F-18 weapons separation, Ship Suitability and the T-45 Goshawk. Following his tour at Patuxent River, Wiseman reported to Carrier Air Wing Seventeen as the Strike Operations Officer, where he completed a deployment around South America. From there, he was assigned to Strike Fighter Squadron 103, Naval Air Station Oceana, Virginia, flying the FA-18F Super Hornet. He was deployed to the Middle East when he was selected for astronaut training. Wiseman reported to the Johnson Space Center in August 2009 and completed astronaut candidate training in May 2011. He served as flight engineer aboard the International Space Station for Expedition 41. The three crew members of Expedition 41 returned to earth on Sunday, November 9, 2014, in Arkalyk, Kazakhstan after a 165 day mission that included hundreds of scientific experiments and several spacewalks. They set a milestone for station science by completing a record 82 hours of research in a single week in July. He has received Air Medal with Combat V (five awards), Navy and Marine Corps Commendation Medal with Combat V (four awards), Navy and Marine Corps Achievement Medal, and various other campaign and service awards.